We have shown that expression of the Alox5 gene is upregulated by BCR-ABL in CML LSCs [36], and it has been reported that Alox5 activates p-Akt through oxidation and inhibition of Pten [37]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.